| |
| |
Good evening. This snapshot of stories and roundup is recommended just for you, based on your interests and reading history. | | | | (Matt McClain/The Washington Post) | | | | | | |  What to know The U.S. Supreme Court will consider Bayer’s appeal over Roundup lawsuits alleging failure to warn about cancer risks. The case could impact the ability to sue over glyphosate, Roundup’s active ingredient. Bayer argues federal law preempts state lawsuits, as the EPA doesn’t classify glyphosate as a carcinogen. Summary is AI-generated, newsroom-reviewed. What are your thoughts on the Supreme Court's decision to review Monsanto's bid for immunity in Roundup lawsuits? | | | | Opinion Letters to the Editor | | | | How was today's newsletter? | | | | | | | | |
Have a question? Ask the Post AI to learn more 
